Immunologic and biophysical features of the BNT162b2 JN.1 and KP.2 adapted COVID-19 vaccines

W Wei Chen K Kristin R. Tompkins I Ian W. Windsor L Lyndsey T. Martinez M Minah Ramos W Weiqiang Li S Shikha Shrivastava S Swati Rajput J Jeanne S. Chang P Parag Sahasrabudhe K Kimberly F. Fennell T Thomas J. McLellan G Graham M. West (Pfizer Worldwide Research and Development) K Kristianne P. Dizon A Aaron Yam S Siddartha Mitra S Subrata Saha D Daiana Sharaf A Andrew P. McKeen C Carla I. Cadima A Alexander Muik W Wesley Swanson R Raquel Munoz Moreno P Pilar Mendoza Daroca U Uğur Şahin A Annaliesa S. Anderson (Vaccine Research and Development, Pfizer, Pearl River, NY) H Huixian Wu K Kena A. Swanson K Kayvon Modjarrad

Article Details

Volume / Issue Vol. 16, Issue 1
Published December 05, 2025
ISSN 2041-1723
Publisher Nature Portfolio

Journal Info

Nature Communications

Nature Portfolio

ISSN: 2041-1723 Open Access Life Sciences

Authors (29)

W

Wei Chen

K

Kristin R. Tompkins

I

Ian W. Windsor

L

Lyndsey T. Martinez

M

Minah Ramos

W

Weiqiang Li

S

Shikha Shrivastava

S

Swati Rajput

J

Jeanne S. Chang

P

Parag Sahasrabudhe

K

Kimberly F. Fennell

T

Thomas J. McLellan

G

Graham M. West

Pfizer Worldwide Research and Development

K

Kristianne P. Dizon

A

Aaron Yam

S

Siddartha Mitra

S

Subrata Saha

D

Daiana Sharaf

A

Andrew P. McKeen

C

Carla I. Cadima

A

Alexander Muik

W

Wesley Swanson

R

Raquel Munoz Moreno

P

Pilar Mendoza Daroca

U

Uğur Şahin

A

Annaliesa S. Anderson

Vaccine Research and Development, Pfizer, Pearl River, NY

H

Huixian Wu

K

Kena A. Swanson

K

Kayvon Modjarrad